Cytarabine – Interleukin Related interleukin-related.com

Product Name :
Cytarabine

Search keywords :
Cytarabine

drugId :
null

Target Vo:
DNA-directed DNA polymerase

Target Vo Short Name :
DNA-directed DNA polymerase

Moa_Name:
DNA-directed DNA polymerase inhibitors

First Approval Country :
United States

First Approval Date Filter:
1969

Origin Company_Name :
Teva

Active Company_Name :
Bei Jing Scrianen Pharmaceutical Co Ltd

Active Indication_Name:
Leukemia, Biphenotypic, Acute

In Active Indication_Name:
Lymphoma, B-Cell

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cdk6 Antibody
ERK1/2 Antibody
CDX2 Antibody: CDX2 Antibody is an unconjugated, approximately 34 kDa, rabbit-derived, anti-CDX2 monoclonal antibody. CDX2 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts